https://www.selleckchem.com/pr....oducts/4-hydroxytamo
Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in controlling exacerbations and improving airway inflammation than either monotherapy. Further studies have suggested that LABAs may have inherent anti-inflammatory potential, but this has not been well-studied. We hypothesize that the
Proudly founded in Rochester, NY, our multi-speciality team of therapists, physicians, psychiatric nurse practitioners, and wellness professionals are dedicated to the use of an individualized, whole-person approach and affordability for every client.